Sage Journals: Discover world-class research

Abstract

Purpose of the Review:

Attention-deficit/hyperactivity disorder (ADHD) is increasingly recognized as a neurodevelopmental disorder that persists into adulthood, associated with functional impairments and psychiatric comorbidities. Global estimates range from 2% to 7%, with higher rates reported in low- and middle-income countries (LMICs). In India, where a large proportion of the population is young, understanding the prevalence and clinical profile of adult ADHD is vital for public health. This article aims to summarize the existing evidence on adult ADHD in India, focusing on prevalence patterns, clinical correlates, and methodological challenges.

Collection and Analysis of Data:

Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a systematic review was conducted using PubMed and Google Scholar up to August 2025. Original studies reporting prevalence or clinical features of adult ADHD in India were included, while reviews, case reports, and studies of Indian populations abroad were excluded. Twenty-four studies were identified and synthesized narratively with attention to conceptualization, prevalence, comorbidities, and cultural influences.

Conclusions:

Prevalence estimates varied across settings. Community and student samples reported rates between 5.5% and 23.3%, with the inattentive subtype consistently dominant. Clinical and substance use disorder (SUD) populations demonstrated higher prevalence, ranging from 18% in opioid-dependent inpatients to 62% in alcohol-dependent cohorts. Comorbidities commonly included depression, anxiety, bipolar disorder, and substance dependence, with ADHD amplifying illness severity and relapse risk. Gender disparities were evident, with women often underdiagnosed due to internalizing presentations. Methodological gaps included reliance on self-report tools, limited retrospective childhood confirmation, and a lack of intervention trials. Adult ADHD in India shows higher prevalence and distinctive cultural influences compared with global estimates. Standardized diagnostic protocols, gender-sensitive approaches, and culturally adapted interventions are urgently needed to improve recognition and care.

Keywords

Adult attention-deficit/hyperactivity disorder India prevalence

Introduction

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent symptoms of inattention, hyperactivity, and impulsivity.¹ Historically, ADHD was conceptualized as a childhood-limited disorder, with the assumption that symptoms remit during adolescence.² However, longitudinal studies over the past two decades have challenged this view, showing that ADHD frequently persists into adulthood and, in some cases, may even first emerge later in life.^3,4 Previously, ADHD was recognized as a childhood- onset condition that persisted into adulthood, referred to as persistent ADHD, whereas cases emerging later in life were characterized as late-onset ADHD.⁵ While the persistence model is well established,⁶ some researchers debate the validity of late-onset ADHD. Some argue that such cases may reflect previously undetected childhood ADHD or the influence of comorbidities^7,8 while others contend that late-onset ADHD is a distinct subtype influenced by environmental and developmental triggers.^5,9,10 This conceptual debate reflects the heterogeneity of ADHD and its interaction with psychosocial, biological, and cultural factors.^11,12

The global prevalence estimates suggest that approximately 2%–3% of adults meet criteria for persistent ADHD, while 5%–7% may present with symptomatic ADHD depending on diagnostic criteria and methodology.¹³ A systematic review and meta-analysis highlighted that prevalence estimates are generally higher in low- and middle- income countries (LMICs) than in high-income settings.¹⁴ For instance, persistent and symptomatic adult ADHD were estimated at 3.25% and 7.66% in high-income countries, compared with 8% and 10.68% in LMICs.¹⁴

With nearly 65% of India’s population below 35 years, understanding adult ADHD is especially relevant, particularly as Indian studies report a higher prevalence than Western countries.^15–18 Indian studies report relatively high prevalence of adult ADHD, such as 14% among college students in Delhi-National Capital Region (NCR) and nearly 25% among fishermen in South India.²⁰ Despite such findings, adult ADHD remains under- recognized in clinical practice.^21,22 Limited awareness among healthcare providers, diagnostic overshadowing by comorbidities, and cultural stigma surrounding mental health contribute to widespread underdiagnosis of adult ADHD in India, resulting in significant psychosocial and economic burden.^21,23

The clinical presentation of adult ADHD differs from childhood forms. While hyperactivity is prominent in early life, these symptoms often diminish with age; meanwhile, inattentive symptoms, disorganization, impulsivity, and emotional dysregulation persist, or become more pronounced.^24,25 Adults with ADHD frequently report difficulties with time management, sustaining attention in occupational tasks, maintaining relationships, and regulating emotions.^26,27 Comorbid conditions such as depression, anxiety, bipolar disorder, and substance use frequently co-occur, complicating diagnosis and worsening functional impairments.^28,29

Despite this burden, adult ADHD remains underdiagnosed and undertreated in India. Limited India-specific research, lack of culturally adapted diagnostic tools, and normalization of ADHD-like symptoms within Indian society contribute to delayed diagnosis, often until comorbid psychiatric or medical conditions become evident.^21,28,30

In our previous systematic review,⁹ we examined the prevalence of adult ADHD in India and demonstrated that the disorder is not uncommon in young adults or clinical populations. Building on that foundation, the present review extends the scope to explore not only prevalence but also the conceptual underpinnings and clinical profiles of adult ADHD, with attention to symptomatology, comorbidities, functional impairments, and cultural considerations. By situating Indian findings within the global evidence base, this review aims to provide a comprehensive synthesis and highlight key priorities for future research, clinical practice, and policy.

Methodology

Study Design

This study is a systematic review conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines. The review exclusively focused on studies conducted in India that examined the concept, prevalence, and clinical profile of adult ADHD. The review protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO; Registration ID: CRD420251142924).

Search Strategy

An electronic search was conducted, encompassing all studies published up to August 2025, using PubMed and Google Scholar. The search terms and syntax used for PubMed were (adult ADHD OR ADHD OR attention-deficit disorder with hyperactivity OR hyperactivity disorder OR attention-deficit hyperactivity disorder OR ADHD attention-deficit hyperactivity disorder OR ADDH OR hyperkinetic disorder OR attention-deficit disorder hyperactivity OR attention-deficit disorders hyperactivity OR child attention-deficit disorder OR hyperkinetic syndromes OR syndromes hyperkinetic OR hyperkinetic syndrome adult OR India*) AND (adult ADHD OR ADHD OR attention-deficit disorder with hyperactivity OR hyperactivity disorder OR attention-deficit hyperactivity disorder OR ADHD attention-deficit hyperactivity disorder OR ADDH OR hyperkinetic disorder OR attention-deficit disorder hyperactivity OR attention-deficit disorders hyperactivity OR child attention-deficit disorder OR hyperkinetic syndromes OR syndromes hyperkinetic OR hyperkinetic syndrome adult) AND (Prevalence) AND (India*). Further articles were searched on Google Scholar, and the search terms related to adult ADHD, prevalence, and epidemiology in India were used to look for appropriate results. The search terms used were (“adult ADHD” OR “adult attention-deficit/hyperactivity disorder”) AND (India OR Indian) AND (prevalence OR epidemiology OR “clinical profile”)

Inclusion and Exclusion Criteria

The following inclusion criteria were considered for selecting articles: (a) All original articles on the prevalence of adult ADHD in India, (b) studies that have employed a categorical diagnosis of ADHD. The exclusion criteria for the review were as follows: (a) Studies on the prevalence of adult ADHD among Indians not residing in India, (b) case reports, editorials, and reviews; and (c) studies with incomplete or unclear information regarding diagnostic tools.

Result and Discussion

Study Selection and Characteristics of Included Studies

The literature search initially yielded 5047 records, including 497 from PubMed and 4550 from Google Scholar. After removal of duplicates and screening by title and abstract, 24 studies met the inclusion criteria (Figure 1).

Figure 1.

Source: Author compilation based on data extracted from included studies.

The included studies were conducted between 2000 and 2025 across multiple Indian regions, such as Delhi NCR, Karnataka, Kerala, Gujarat, Rajasthan, and the North-East.^{19,20,31–52} Samples included community, student, and clinical groups (psychiatric and substance use populations) (Table 1). Most studies were cross-sectional in design and employed validated instruments, most commonly the Adult ADHD Self-Report Scale (ASRS v1.1), followed by the Wender Utah Rating Scale (WURS) and Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV/DSM-5-based diagnostic interviews.^31,44,47,50

Table 1.

Characteristics of Included Studies.

Author (Year)	Region/State	Population	Age Group	Diagnostic Tool
Sitholey et al., 2009	Lucknow, Uttar Pradesh	Psychiatric/de-addiction OPD	18–45	ASRS v1.1; DSM-IV-TR; WURS
Jhambh et al., 2014	Chandigarh, North India	College students	18–25	ASRS v1.1 + WURS
Pattanshetti et al., 2016	Belagavi, Karnataka	Bipolar disorder (remission)	≥17	ASRS v1.1 + DSM-5
Shah et al., 2016	Jaipur, Rajasthan	Young male smokers	18–25	ASRS v1.1 (6-item); FTND
Ganesh et al., 2017	Bengaluru, Karnataka	Male SUD patients	Adults	ASRS Checklist
Kumar et al., 2017a	Bengaluru, Karnataka	Male college students	16–25	ASRS v1.1 + WURS
Kumar et al., 2017b	Puducherry	Fishermen	≥18	ASRS v1.1 (Tamil); AUDIT
Jaisoorya et al., 2017	Ernakulam, Kerala	College students	18–25	K10; WHO ASSIST; BAARS-IV
Kumar et al., 2018	Karnataka	Alcohol-dependent men vs. controls	18–60	ASRS v1.1; DSM-5
Goutam et al., 2018	Ujjain, Madhya Pradesh	Medical/paramedical students	≥18	ASRS v1.1 + DSM-IV-TR
Jaisoorya et al., 2018	Ernakulam, Kerala	College students (58 colleges)	18–25	WHO ASSIST; BAARS-IV
Jhaveri et al., 2019	Ahmedabad, Gujarat	University undergraduates	≥18	ASRS v1.1 (DSM-IV-TR)
Lohit et al., 2019	Dharwad, Karnataka	Alcohol use disorder (male)	18–60	ASRS v1.1 + DSM-5
Gupta et al., 2020	New Delhi and Bhopal	Opioid-dependent males	≥18	ASRS v1.1; MINI 5.0
Patel and Parikh, 2021	Ahmedabad, Gujarat	College students	18–24	ASRS v1.1 (DSM-IV-TR)
Jaisoorya et al., 2021	Ernakulam, Kerala	College students (58 colleges)	18–25	WHO ASSIST; BAARS-IV
Samal et al., 2022	Odisha and Manipur	SUD adults	18–65	ASRS v1.1; DSM-5
Mishra et al., 2023	Bihar and Rajasthan	Bipolar (euthymic) patients	18–65	WURS-25; ASRS-5; DSM-5
Victor et al., 2023	Dehradun, Uttarakhand	Substance-dependent adults	24–29	ASRS v1.1 + ICD-10
Mishra et al., 2024	Delhi NCR	College students	18–25	ASRS v1.1
Singh et al., 2024	Punjab	Higher-ed students	17–23	ASRS v1.1
Goyal et al., 2025	Bengaluru (NIMHANS)	Adults with ADHD	18–45	DSM-5 + ASRS v1.1
Singh et al., 2025	Pune, Maharashtra	Alcohol-dependent inpatients	18–65	ASRS v1.1; ICD-10 DCR
Mishra et al., 2025	Delhi NCR	College students	18–25	ASRS v1.1; BMI, BP (AHA)

Source: Author compilation based on data extracted from included studies.

Note: ASRS = Adult ADHD Self-Report Scale; DSM = Diagnostic and Statistical Manual of Mental Disorders; WURS = Wender Utah Rating Scale; WHO ASSIST = Alcohol, Smoking, and Substance Involvement Screening Test; BAARS-IV = Barkley Adult ADHD Rating Scale-IV; FTND = Fagerström Test for Nicotine Dependence; AUDIT = Alcohol Use Disorders Identification Test; MINI = Mini International Neuropsychiatric Interview; SUD = Substance Use Disorder; OPD = Outpatient Department; BP = Blood Pressure; AHA = American Heart Association.

Concept of ADHD

Indian research presents a complex understanding of ADHD in adulthood. While international literature now defines ADHD as a lifespan neurodevelopmental disorder. Indian research shows an uneven representation of this global trajectory. Among student and community populations, ADHD has often been examined through the lens of functional outcomes. Few studies employed the ASRS v1.1 to assess current symptoms in college students, linking them with academic stress, sociodemographic variation, and regional background.^19,39 Some studies similarly relied on symptom checklists, treating ADHD primarily as a functional construct rather than a diagnostic entity.^33,42

Only a few studies incorporated retrospective childhood measures such as the WURS or Barkley Adult ADHD Rating Scale-IV (BAARS-IV), thereby aligning more closely with DSM-based requirements^31,32,44,47 (Table 2). Overall, the absence of systematic childhood-onset confirmation in most of these investigations demonstrates a gap between Indian research practices and international nosology. Yet these studies highlight important functional consequences of ADHD in young adults, ranging from poor academic performance and emotional instability to association with behavioral factors such as substance use and unsafe sexual practices.

Table 2.

Conceptualization of Adult ADHD in Included Indian Studies.

Author (Year)	Definition/Concept Adopted	Childhood-onset Considered	Focus (Clinical vs. Functional)
Sitholey et al., 2009	ADHD as a lifespan neurodevelopmental disorder (DSM-IV-TR, ASRS, WURS)	Yes	Clinical + functional
Jhambh et al., 2014	ADHD requiring both adult (ASRS) and childhood (WURS) symptoms	Yes	Functional
Pattanshetti et al., 2016	ADHD is conceptualized as persisting in bipolar disorder (ASRS + DSM-5)	No	Clinical
Shah et al., 2016	Adult ADHD persistence screened via ASRS (6-item)	No	Functional + clinical
Ganesh et al., 2017	ADHD as a developmental disorder persisting into adulthood (ASRS)	No	Clinical
Kumar et al., 2017a	ADHD identified through ASRS (current) and WURS (childhood)	Yes	Functional + clinical
Kumar et al., 2017b	Adult ADHD screened via Tamil ASRS	No	Functional + clinical
Jaisoorya et al., 2017	Retrospective ADHD linked to psychological distress (K10)	Yes	Functional + clinical
Kumar et al., 2018	ADHD diagnosed in alcohol-dependent adults (DSM-5 + ASRS)	No	Clinical
Goutam et al., 2018	ADHD as executive dysfunction (ASRS + DSM-IV-TR)	Yes	Functional + clinical
Jaisoorya et al., 2018	Retrospective ADHD symptoms (BAARS-IV, ages 5-12)	Yes	Functional + clinical
Jhaveri et al., 2019	ADHD conceptualized via ASRS symptom screening	No	Functional
Lohit et al., 2019	ADHD defined per DSM-5; onset <12 yrs	Yes	Clinical
Gupta et al., 2020	DSM-IV-TR ADHD screened in opioid-dependent adults	No	Clinical + functional
Patel & Parikh, 2021	ADHD per DSM-IV-TR, screened via ASRS	No	Functional
Jaisoorya et al., 2021	Retrospective ADHD (BAARS-IV) assessing adult persistence	Yes	Functional
Samal et al., 2022	ADHD as a persisting neurodevelopmental disorder (DSM-5 + ASRS)	No	Functional + clinical
Mishra et al., 2023	Adult ADHD confirmed via WURS + DSM-5	Yes	Clinical + functional
Victor et al., 2023	ADHD is a neurodevelopmental condition linked with SUD (ASRS + ICD-10)	No	Clinical + functional
Mishra et al., 2024	Adult ADHD is defined by ASRS v1.1 (inattention, hyperactivity, impulsivity)	No	Functional
Singh et al., 2024	ADHD conceptualized through ASRS v1.1 traits	No	Functional
Goyal et al., 2025	ADHD defined per DSM-5; clinical diagnosis + validated scales	Yes	Clinical + functional
Singh et al., 2025	ADHD as a neurodevelopmental disorder (ASRS + ICD-10 DCR)	No	Clinical
Mishra et al., 2025	ADHD is defined by current symptomatic criteria (ASRS v1.1)	No	Functional /epidemiological

Source: Author compilation based on data extracted from included studies.

Note: ASRS = Adult ADHD Self-Report Scale; WURS = Wender Utah Rating Scale; DSM-IV-TR / DSM-5 = Diagnostic and Statistical Manual of Mental Disorders (4th Edition, Text Revision / 5th Edition); BAARS-IV = Barkley Adult ADHD Rating Scale-IV; K10 = Kessler Psychological Distress Scale; ICD-10 DCR = International Classification of Diseases, 10th Revision-Diagnostic Criteria for Research; SUD = Substance Use Disorder; BD = Bipolar Disorder; SES = Socioeconomic Status; NE India = North-East India; BP = Blood Pressure; Func. = Functional; Clin. = Clinical.

In parallel, another set of studies examined the comorbid conditions associated with ADHD, underscoring its broader clinical and psychosocial implications beyond functional impairments. The studies on diagnosed ADHD individuals revealed a persistent co-occurrence of ADHD with alcohol use.^36,37,40,51 In alcohol-dependent populations, ADHD has been portrayed as a psychiatric comorbidity with direct implications for illness trajectory. Similarly, studies also show a strong association of ADHD with other substance use disorders (SUDs), including heroin, cannabis, and opioid.^35,41,46,49

Beyond addiction, ADHD has also been examined as a modifier of psychiatric illness. A study reported ADHD in patients with bipolar disorder in remission,³⁴ while another study found that comorbid ADHD predicted earlier illness onset, higher episode frequency, and increased suicidality.⁴⁷ Another study further emphasized developmental continuity by documenting childhood-onset in more than 90% of clinically diagnosed adult ADHD patients in a tertiary-care setting.⁵⁰

Indian research reveals two conceptualizations of ADHD. Community studies view it as a functional, symptom- based construct linked to academics or behavior, while clinical studies treat it as a DSM/ICD-defined disorder with comorbidity and prognosis. However, inconsistent methods and the lack of culturally validated tools persist. Most studies rely on untranslated ASRS or WURS scales, and only one study used a Tamil version of the ASRS, highlighting the need for psychometric adaptation in India.²⁰

These findings indicate that ADHD symptoms are common among Indian students but are often normalized as outcomes of academic or lifestyle stress.^19,39 This functional interpretation reflects a broader trend in low and middle-income settings, where psychological distress is attributed to external pressures rather than neurodevelopmental causes. Consequently, adult ADHD remains under-recognized, limiting clinical referrals and targeted interventions.²¹ The developmental vulnerability hypothesis is supported, suggesting that impulsivity and reward dysregulation in ADHD increase susceptibility to addictive behaviors. Cultural factors such as permissive drinking norms in fishing communities or easy access to opioids in the North East further intensify these risks. Moreover, ADHD interacts with affective and behavioral systems, shaping illness trajectories and contributing to diagnostic overshadowing in psychiatric settings. The most distinctive contribution of Indian research lies in its cultural contextualization. Studies among migrating students in Delhi, reflecting cultural and environmental differences between North and South India that create adaptation challenges¹⁹ along with fishermen in Puducherry,²⁰ military personnel in Pune,⁵¹ and North-Eastern populations, illustrate this diversity.⁴⁶

Prevalence of ADHD

The prevalence of adult ADHD in India has been examined across diverse populations, including students, community samples, SUD patients, alcohol-dependent cohorts, and psychiatric populations (Table 3). Estimates vary widely, reflecting methodological differences, population characteristics, and contextual influences.

Table 3.

Prevalence of Adult ADHD Reported in Indian Studies.

Author (Year)	Region	Prevalence (%)	Diagnostic Tool	Sample Type
Sitholey et al., 2009	Lucknow (U.P.)	8.8	ASRS + DSM-IV-TR + WURS	Psychiatric outpatients and relatives
Jhambh et al., 2014	Chandigarh	5.5	ASRS + WURS	237 college students
Shah et al., 2016	Jaipur	19	ASRS + FTND	100 male smokers
Pattanshetti et al., 2016	Belagavi	15	ASRS + DSM-5	100 bipolar patients (remission)
Ganesh et al., 2017	Bengaluru	56	ASRS v1.1	240 male SUD patients
Kumar et al., 2017a	Bengaluru	14.8	ASRS + WURS	270 male students
Kumar et al., 2017b	Puducherry	25.7	ASRS + AUDIT	304 fishermen
Goutam et al., 2018	Ujjain (M.P.)	15.9	ASRS + DSM-IV-TR	353 medical/paramedical students
Jhaveri et al., 2019	Ahmedabad	3.3	ASRS v1.1	300 undergraduates
Lohit et al., 2019	Karnataka	19	ASRS + DSM-5 interview	100 male AUD inpatients
Gupta et al., 2020	North India	18.2	ASRS v1.1	132 opioid-dependent inpatients
Patel & Parikh, 2021	Ahmedabad	11.4	ASRS v1.1	307 young adults
Samal et al., 2022	North-East India	24.3	ASRS v1.1	210 SUD patients
Mishra et al., 2023	Bihar and Rajasthan	27 (lifetime)	WURS-25 + ASRS-5 + DSM-5	110 euthymic bipolar patients
Victor et al., 2023	Uttarakhand	33	ASRS + ICD-10	153 substance-dependent adults
Mishra et al., 2024	Delhi NCR	14	ASRS v1.1	1,665 students (18–25; 69% female)
Singh et al., 2024	Punjab	23.3 (symptom-level)	ASRS v1.1	360 students (228 female, 132 male)
Singh et al., 2025	Pune	11.9	ASRS + ICD-10 DCR	177 male alcohol inpatients

Source: Author compilation based on data extracted from included studies.

Note: ASRS = Adult ADHD Self-report Scale; DSM-IV-TR = Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision; DSM-5 = Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition; WURS = Wender Utah Rating Scale; FTND = Fagerström Test for Nicotine Dependence; AUDIT = Alcohol Use Disorders Identification Test; ICD-10 = International Classification of Diseases, Tenth Revision; ICD-10 DCR = International Classification of Diseases, Tenth Revision, Diagnostic Criteria for Research.

In community and population-based studies, prevalence ranged from 5.5% in Chandigarh to 23.3% in Punjab.^32,52 Mid-range estimates included 14% in Delhi-NCR¹⁹ and 15.9% in Ujjain.³⁸ Across community-based studies, the inattentive subtype was consistently dominant; in Delhi, nearly two-thirds of ADHD cases belonged to this subtype.¹⁹ These rates are broadly higher than those reported from Western population-based studies, indicating possible contextual amplification, or diagnostic overestimation.

Functional impairments were common, including emotional instability, low self-esteem, poor academic performance, and risky sexual behaviors,^32,37 among individuals with ADHD.^32,37 Interestingly, higher maternal education and South Indian origin were associated with increased ADHD risk, whereas low socioeconomic status appeared protective in Delhi students, possibly reflecting reduced academic competition or differing cultural expectations.¹⁹ MBBS students in Ujjain showed a higher prevalence compared to physiotherapy and nursing peers.³⁸ These findings suggest that ADHD in young adults is shaped not only by symptom profiles but also by sociocultural and academic contexts, such as migration-related stress and competitive education environments. Studies conducted among students or in community settings appear to yield higher ADHD prevalence when compared with the global estimates, ranging from 2.5% to 5%.^4,14

While student and community studies depict ADHD as relatively common, clinical populations show even higher prevalence and stronger associations with comorbidities. In alcohol and SUD populations, prevalence estimates were markedly higher, ranging from 18.2% among opioid- dependent inpatients to 62% among alcohol-dependent men in Karnataka.⁴¹ A study reported that 56% of SUD patients screened positive for ADHD symptoms, with early-onset dependence groups showing significantly higher ADHD prevalence.³⁵ Another study reported 33% prevalence in substance-dependent adults, with cannabis users most affected (47.6%),⁴⁹ while another study found 24.3% prevalence in North-East India, with polysubstance users reaching 65%.⁴⁶ Clinical remarks across studies reveal that ADHD-positive patients were younger, consumed more alcohol daily, relapsed earlier, and had higher psychiatric comorbidity.^40,52 In Puducherry, fishermen showed a prevalence of 25.7%, doubling to 40% in alcohol-dependent subgroups, reflecting the impact of occupational stress and a pervasive alcohol culture.³⁷ In North-East India, cultural acceptance of alcohol and opioids shaped outcomes, producing higher prevalence rates.⁴⁶ These findings align with global pooled estimates of 23% for SUD populations.⁵³ Meanwhile, in a few studied populations in India, the prevalence exceeded, underscoring how social environments and addiction pathways intensify ADHD expression.⁵⁴

Methodological differences cause wide variation across Indian studies. Most used the ASRS v1.1 for screening, while a few included retrospective tools such as WURS or BAARS-IV, or conducted structured diagnostic interviews. In studies using retrospective confirmation, such as a study among college students reported the prevalence dropped sharply from 23.6% to 5.5%, showing the importance of developmental continuity.³² International research often uses standardized interviews such as Diagnostic Interview for ADHD in Adults, version 2.0 (DIVA 2.0) or Conners’ Adult ADHD Diagnostic Interview for DSM-IV (CAADID) (Ramos-Quiroga), producing more accurate and consistent results. Reducing these methodological gaps is crucial to developing reliable national estimates and improving adult ADHD screening practices in India.

Clinical Profile of ADHD

Indian studies on adult ADHD have mainly focused on inattention and hyperactivity/impulsivity, with most using the ASRS v1.1 as the primary screening tool. Across community and student populations, the inattentive subtype consistently appears most common. A study reported that 62.6% of ADHD-positive college students in Delhi NCR were inattentive,¹⁹ while similar trends were reported among college students in Chandigarh and Madhya Pradesh^32,38 (Table 4). Even in studies with lower prevalence, inattentive subtypes dominated, accounting for roughly 35%-63% of cases.^42,52 These results align with international findings, showing that hyperactivity declines with age while inattention remains the defining feature in adulthood.⁵⁵

Table 4.

Clinical Profile and Comorbidities of Adult ADHD in Indian Studies.

Author (Year)	Symptom Domains / Subtypes	Common Comorbidities	Major Functional Impairments	Clinical / Management Notes
Sitholey et al., 2009	Inattention, hyperactivity, impulsivity (DSM-IV-TR; WURS)	ODD, MDD, SUD, anxiety, BD	Poor academics, work difficulty, and relationship strain	Early Indian clinical profiling; 80% ≥1 comorbidity
Pattanshetti et al., 2016	Inattentive (47%), combined (33%), NOS (20%)	Alcohol, GAD, OCD, and cannabis use	Earlier onset of BD, more manic episodes	ADHD linked with illness severity in BPAD
Ganesh et al., 2017	Inattention, hyperactivity (ASRS)	Alcohol, cannabis, opioids, polysubstance	Early-onset SUD, poorer outcomes	ADHD–SUD comorbidity is clinically significant
Kumar et al., 2017a	Mixed (inattentive, hyperactive)	Substance use	Academic decline, risky sexual behavior	Suggests higher impulsivity in ADHD students
Kumar et al., 2018	Hyperactive (52%), inattentive (39%), combined (10%)	Tobacco misuse	Severe alcohol dependence, relapse	ADHD is associated with addiction severity
Goutam et al., 2018	Inattentive (50%), combined (32%), hyperactive (18%)	Depression, seizure, phobia	Academic difficulty, rash driving, and accidents	ADHD linked with executive dysfunction
Lohit et al., 2019	Combined (47%), hyperactive (42%), inattentive (11%)	Bipolar, depression, anxiety	Faster alcohol progression, higher relapse	ADHD worsens alcohol outcomes
Gupta et al., 2020	Inattention, hyperactivity, impulsivity (ASRS)	Mood (20%), cannabis (35%), nicotine (96%)	Early opioid use, anxiety, and conflict	Highlights ADHD–SUD overlap
Mishra et al., 2023	Inattention, hyperactivity, impulsivity (ASRS; DSM-5)	Bipolar disorder	Early-onset, more episodes, poor psychosocial outcome	ADHD-BD comorbidity aggravates the course
Mishra et al., 2025	Inattention, hyperactivity, impulsivity (ASRS; subtypes ADHD-I, ADHD-H, ADHD-C)	Obesity and hypertension (metabolic comorbidities)	Combined type linked with central obesity; the inattentive type showed a lower BP trend	Early screening and integration of ADHD within obesity-hypertension programs suggested
Singh et al., 2025	Inattention, hyperactivity (ASRS)	Alcohol dependence	Early drinking, greater severity	ADHD linked with faster addiction trajectory
Goyal et al., 2025	Inattention, executive deficits, and emotional dysregulation	Women: depression/anxiety; Men: SUD	Work and social dysfunction, low self-esteem	Gender differences in presentation: 35% treated

Source: Author compilation based on data extracted from included studies.

Note: ASRS = Adult ADHD Self-Report Scale; WURS = Wender Utah Rating Scale; DSM-IV-TR / DSM-5 = Diagnostic and Statistical Manual of Mental Disorders (4th/5th Ed.); SUD = Substance Use Disorder; BD = Bipolar Disorder; BPAD = Bipolar Affective Disorder; ODD = Oppositional Defiant Disorder; MDD = Major Depressive Disorder; OCD = Obsessive–compulsive disorder.

The scope of symptom evaluation extended beyond core domains in clinical samples from India. A study in Bengaluru assessed executive dysfunction, emotional dysregulation, and social cognition, showing that adults with ADHD experienced impairments beyond DSM-defined symptoms.⁵⁰ Women reported greater symptom severity and atypical features such as mind-wandering, hyper-focusing, and mood lability, while men more often showed externalizing behaviors such as substance use.^50,56,57 These gender-specific patterns mirror global findings, where women are frequently underdiagnosed because internalizing symptoms are misattributed to depression, anxiety, or personality disorders.^57–59 Thus, Indian evidence supports international trends while highlighting unique diagnostic barriers for women in low-resource mental health settings.

Comorbidity profiles varied substantially between community and clinical contexts. Student-based studies either did not assess psychiatric comorbidities or reported very low levels; for instance, a study among medical students reported isolated cases of depression and phobias. In contrast, hospital and psychiatric samples showed higher comorbidity, with ADHD prevalence ranging from 15% to 27%.^34,47 Bipolar patients with ADHD displayed greater alcohol dependence, anxiety, OCD, and cannabis use,³⁴ while another study found 27% lifetime ADHD prevalence,⁴⁷ consistent with international estimates.^60,61

Studies revealed a strong, persistent association of alcohol use and ADHD.^62,63 A study identified mood and anxiety disorders among alcohol-dependent populations who are ADHD-positive.⁴⁰ Another study found high ADHD prevalence among alcohol-dependent inpatients,⁵¹ with diagnoses confirmed through DSM-5 criteria, linking ADHD with earlier initiation of drinking, greater severity, and higher relapse rates.⁴⁰ Further evidence from coastal populations showed that occupational pressures and a culture of heavy alcohol consumption interacted with ADHD symptoms.²⁰ A comparative study between alcohol-dependent cases and healthy controls also found that ADHD exacerbated dependence severity.³⁶

Studies on SUDs reveal consistent associations with ADHD. One study reported high ADHD prevalence among treatment-seeking substance users in Bengaluru, particularly those with early-onset dependence.³⁵ Another study identified ADHD among heroin- and cannabis-dependent adults in North India,⁴⁹ while similar patterns were observed in opioid-dependent inpatients, linked to risky behaviors and poorer quality of life.⁴¹ Research from North-East India highlighted how social acceptance of alcohol and opioids shaped the expression of ADHD.⁴⁶ These findings, consistent with the studies that emphasize India-specific factors, occupational alcohol culture²⁰ and stronger ADHD associations with cannabis and opioids,^41,49 with consequences such as relapse, unemployment, and family strain.⁴⁶ Another study reported that nearly 80% of adults with ADHD had at least one psychiatric comorbidity, including major depression, substance use, anxiety, and oppositional defiant disorder.³¹ These results align with global evidence showing that adult ADHD is rarely “pure,” often co-occurring with mood, anxiety, and SUDs.^64,65 The Indian data thus mirror international patterns while highlighting the diagnostic complexity and challenges of managing multimorbid ADHD in resource-limited psychiatric settings.

In alcohol and SUD populations, the functional impact of ADHD was markedly greater. Research showed that ADHD-positive alcohol-dependent patients had earlier onset, faster progression, and more severe ICD-10 dependence features.⁵¹ Another study found shorter abstinence, higher relapse, and severe withdrawal in comorbid cases.⁴⁰ Research also linked early-onset substance use with higher ADHD prevalence, along with greater psychosocial instability across affected groups.^35,46,49 These findings, consistent with global evidence^66–68 suggest sociocultural factors such as fishing- community alcohol culture¹⁹ and regional opioid use intensify outcomes.⁴⁶

In psychiatric populations, comorbid ADHD was linked to more severe illness trajectories. A study reported that noted that ADHD-positive bipolar patients experienced earlier onset, more frequent manic episodes, and higher drug burdens compared with those without ADHD.³⁴ These results align with international research showing that ADHD in psychiatric populations, particularly in bipolar disorder, is associated with a more severe and chronic illness course, higher suicide risk, and poorer psychosocial outcomes.^69–71 Overall, the evidence supports that ADHD functions as a risk amplifier across psychiatric contexts, aggravating functional impairments irrespective of the primary disorder.

Despite substantial evidence of burden, there was a paucity of treatment and management approaches in the Indian literature. None of the reviewed studies conducted structured intervention trials. Most articles limited themselves to recommending early screening, clinician awareness, and integration of ADHD assessment into psychiatric or addiction care pathways. One study emphasized that only 35% of women in their clinical sample received ADHD specific interventions, with most being treated instead for comorbidities, underscoring the problem of diagnostic overshadowing.⁵⁰ Contradictorily, international research provides evidence base for interventions, including stimulants and non-stimulants such as atomoxetine and guanfacine, and cognitive-behavioral therapy have all demonstrated efficacy in improving symptoms and functioning in adult ADHD.^72,73 The lack of Indian intervention studies, therefore, represents a significant gap, highlighting the need for culturally adapted trials that address both psychiatric and functional outcomes.

Indian research shows that adult ADHD involves core attentional deficits, high comorbidity, and significant functional impairments, consistent with international evidence. However, higher prevalence in substance use populations suggests strong contextual influences such as migration stress, occupational drinking culture, and regional drug access. Functional impairments are prominent among students, including poor academics, low self-esteem, and risky behaviors.^32,37,42 These patterns align with global findings linking ADHD to academic failure, impulsivity, and risky sexual or substance use behaviors.^74,75 Yet, intervention research in India remains limited, underscoring the need for evidence-based treatments to support functional recovery.

Conclusion

Adult ADHD is increasingly recognized in India as a clinically and socially significant condition marked by persistent inattention and hyperactivity-impulsivity. Indian evidence shows wide prevalence variation, ranging from 5% to 16% in student and community populations to 18%-62% in psychiatric and substance use cohorts, reflecting methodological diversity and contextual influences. Consistent with global findings, the inattentive subtype predominates, and comorbid mood, anxiety, bipolar, and SUDs are common. Clinical studies reveal that ADHD frequently exacerbates alcohol and drug dependence, accelerates illness progression in bipolar disorder, and contributes to academic, occupational, and social dysfunction.

Distinctive to Indian research are cultural insights linking ADHD expression to migration stress, competitive academic environments, and occupational alcohol norms. However, methodological limitations persist: Most studies rely on self-report screeners without retrospective childhood confirmation or structured diagnostic interviews, and intervention research remains absent. Gender differences are rarely explored, leading to underrecognition among women.

Future research should prioritize standardized diagnostic protocols adapted to Indian contexts, gender-sensitive approaches, integration of ADHD screening into psychiatric and addiction services, and culturally informed treatment trials. Bridging these gaps is crucial to transform diagnostic awareness into effective, evidence-based care for adults with ADHD in India.

Footnotes

Declaration of Conflicting Interests

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Statement of Informed Consent and Ethical Approval

Not Applicable as this article does not report any patient data.

References

Frank-Briggs

. Attention deficit hyperactivity disorder (ADHD). J Pediatr Neurol. 2011;9(3):291–298.

Thapar

, Cooper

, Rutter

. Neurodevelopmental disorders. Lancet Psychiatry. 2017;4(4):339–346.

Caye

, Sibley

, Swanson

, Rohde

. Late-onset ADHD: understanding the evidence and building theoretical frameworks. Curr Psychiatry Rep. 2017;19(12):106.

Polanczyk

, De Lima

, Horta

, Biederman

, Rohde

. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164(6):942–948.

Asherson

, Agnew-Blais

. Annual research review: does late-onset attention-deficit/hyperactivity disorder exist? J Child Psychol Psychiatry. 2019;60(4):333–352.

Sibley

, Mitchell

, Becker

. Method of adult diagnosis influences estimated persistence of childhood ADHD: a systematic review of longitudinal studies. Lancet Psychiatry. 2016;3(12):1157–1165.

Ahmad

, Owens

, Hinshaw

. Little evidence for late-onset ADHD in a longitudinal sample of women. J Consult Clin Psychol. 2019;87(1):112.

Sibley

, Rohde

, Swanson

, . Late-onset ADHD reconsidered with comprehensive repeated assessments between ages 10 and 25. Am J Psychiatry. 2018;175(2):140–149.

Moffitt

, Houts

, Asherson

, . Is adult ADHD a childhood-onset neurodevelopmental disorder? Evidence from a four-decade longitudinal cohort study. Am J Psychiatry. 2015;172(10):967–977.

10.

Agnew-Blais

, Polanczyk

, Danese

, Wertz

, Moffitt

, Arseneault

. Evaluation of the persistence, remission, and emergence of attention-deficit/hyperactivity disorder in young adulthood. JAMA Psychiatry. 2016;73(7):713–720.

11.

Slobodin

, Crunelle

. Mini review: socio-cultural influences on the link between ADHD and SUD. Front Public Health. 2019;7:173.

12.

Lewczuk

, Marcowski

, Wizła

, . Cross-cultural adult ADHD assessment in 42 countries using the adult ADHD self-report scale screener. J Atten Disord. 2024;28(4):512–530.

13.

Fayyad

, Sampson

, Hwang

, . The descriptive epidemiology of DSM-IV adult ADHD in the World Health Organization World Mental Health Surveys. ADHD Atten Def Hyp Disord. 2017;9(1):47–65.

14.

Song

, Zha

, Yang

, Zhang

, Li

, Rudan

. The prevalence of adult attention-deficit hyperactivity disorder: a global systematic review and meta-analysis. J Glob Health. 2021;11:04009.

15.

Estévez

, Eich-Höchli

, Dey

, Gmel

, Studer

, Mohler-Kuo

. Prevalence of and associated factors for adult attention deficit hyperactivity disorder in young Swiss men. PLoS One. 2014;9(2):e89298.

16.

Moulin

, Chollet

, Ramos-Quiroga

, Bouvard

, Melchior

, Galéra

. Prevalence and psychosocial correlates of ADHD symptoms in young adulthood: a French population-based study. J Atten Disord. 2018;22(2):167–181.

17.

Stickley

, Koyanagi

, Takahashi

, Ruchkin

, Inoue

, Kamio

. Attention-deficit/hyperactivity disorder and physical multimorbidity: a population-based study. Eur Psychiatry. 2017;45:227–234.

18.

Syrstad

VEG

, Oedegaard

, Fasmer

, . Cyclothymic temperament: associations with ADHD, other psychopathology, and medical morbidity in the general population. J Affect Disord. 2020;260:440–447.

19.

Mishra

, Chaudhary

, Saraswathy

, Shekhawat

, Devi

. Prevalence of adult attention deficit hyperactivity disorder in India: a systematic review and a cross-sectional study among young adults in Delhi-NCR. Soc Psychiatry Psychiatr Epidemiol. 2024;60(4):785–796.

20.

Kumar

, Bharadwaj

, Kuppili

, . Association of attention-deficit hyperkinetic disorder with alcohol use disorders in fishermen. J Neurosci Rural Pract. 2017;8(1):S078-S082.

21.

Ginsberg

, Quintero

, Anand

, Casillas

, Upadhyaya

. Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: a review of the literature. Prim Care Companion CNS Disord. 2014;16(3):1–8.

22.

Jain

, Jain

, Montano

. Addressing diagnosis and treatment gaps in adults with attention-deficit/hyperactivity disorder. Prim Care Companion CNS Disord. 2017;19(5):17nr02153.

23.

Asherson

, Akehurst

, Kooij

, . Under diagnosis of adult ADHD: cultural influences and societal burden. J Atten Disord. 2012;16(5 Suppl):20S-38S.

24.

Asherson

, Manor

, Huss

. Attention-deficit/hyperactivity disorder in adults: update on clinical presentation and care. Neuropsychiatry. 2014;4(1):109.

25.

Corbisiero

, Stieglitz

, Retz

, Rösler

. Is emotional dysregulation part of the psychopathology of ADHD in adults? Atten Defic Hyperact Disord. 2013;5(2):83–92.

26.

Gillig

, Gentile

, Atiq

. Attention-deficit/hyperactivity disorder in adults. Psychiatry (Edgmont). 2005;9(2):1.

27.

Mao

, Brams

, Babcock

, Madhoo

. A physician’s guide to helping patients with ADHD find success in the workplace. Postgrad Med. 2011;123(5):60–70.

28.

Anbarasan

, Adler

. How co-traveling accessory symptoms and comorbidities affect making the diagnosis of adult ADHD. Psychiatr Ann. 2024;54(12):e325-e329.

29.

Katzman

, Bilkey

, Chokka

, Fallu

, Klassen

. Adult ADHD and comorbid disorders: clinical implications of a dimensional approach. BMC Psychiatry. 2017;17(1):302.

30.

Gore

, Morgan

. Children with attention deficit hyperactivity disorder in India: strengthening diagnosis, support, training and research. J Indian Assoc Child Adolesc Ment Health. 2025;21(1):17–22.

31.

Sitholey

, Agarwal

, Sharma

. An exploratory clinical study of adult attention deficit/hyperactivity disorder from India. Indian J Med Res. 2009;129(1):83–88.

32.

Jhambh

, Arun

, Garg

. Cross-sectional study of self-reported ADHD symptoms and psychological comorbidity among college students in Chandigarh, India. Ind Psychiatry J. 2014;23(2):111–116.

33.

Shah

, Singh

, Soni

, Kumar

. Screening for adult attention deficit hyperactivity disorder (ADHD) in young male smokers: a cross-sectional study. Int J Health Sci Res. 2016;6(8):73–79.

34.

Pattanshetti

, Patil

, Tekkalaki

. Prevalence of adult attention deficit hyperactivity disorder in patients with bipolar affective disorder: a 1-year hospital-based cross-sectional study. Indian J Health Sci Biomed Res KLEU. 2016;9(3):288–296.

35.

Ganesh

, Kandasamy

, Sahayaraj

, Benegal

. Adult attention deficit hyperactivity disorder in patients with substance use disorders: a study from Southern India. Indian J Psychol Med. 2017;39(1):59–62.

36.

Kumar

, Chate

, Patil

, Tekalaki

, Patil

. Prevalence of undiagnosed and untreated attention deficit hyperactivity disorder in men with alcohol dependence: a case-control study. Psychiatry Psychother. 2018;20:26–32.

37.

Kumar

, Pandiyan

, Huilgol

, Hongally

. Prevalence and correlates of adult attention deficit disorder (ADHD) among college-going young adult males with risky sexual behaviour. J Evol Med Dent Sci. 2017;6(17):1367–1370.

38.

Pritesh

, Rituja

, Mahima

. A study to calculate prevalence of adult attention deficit disorder in medical and paramedical students of Central India and its association with various risk factors. Indian J Ment Health. 2018;5(204):2018–2024.

39.

Jhaveri

, Rana

, Shah

, Malhotra

. Detection and evaluation of attention deficit hyperkinetic disorder (ADHD) in adult Indian students of different programmes using adult self-report scale v1.1. Natl J Integr Res Med. 2019;10(5):28–34.

40.

Lohit

, Babu

, Sharma

, Rao

, Sachin

, Matkar

. Prevalence of adult ADHD comorbidity in alcohol use disorders in a general hospital setup. Indian J Psychol Med. 2019;41(6):523–528.

41.

Gupta

, Bhatia

, Sarkar

, Chatterjee

, Balhara

YPS

, Dhawan

. Adult attention-deficit hyperactivity disorder and its correlates in patients with opioid dependence: an exploratory study. Indian J Psychiatry. 2020;62(5):501–508.

42.

Patel

, Parikh

. Prevalence of attention deficit hyperactivity disorder-ADHD among young individuals: an observational study. Int J Sci Health Res. 2021;6(3):25–29.

43.

Jaisoorya

, Ganjekar

, Menon

, Nair

, Rani

, Thennarassu

. Tobacco use among college students in Kerala, India. Indian J Med Res. 2021;154(3):527–532.

44.

Jaisoorya

, Gowda

, Nair

, . Correlates of high-risk and low-risk alcohol use among college students in Kerala, India. J Psychoactive Drugs. 2018;50(1):54–61.

45.

Jaisoorya

, Rani

, Menon

, . Psychological distress among college students in Kerala, India—prevalence and correlates. Asian J Psychiatry. 2017;28:28–31.

46.

Samal

, Senjam

, Ravan

, Ningombam

, Das

. Prevalence of adult ADHD in patients with substance use disorder in North East India. Ind Psychiatry J. 2022;31(2):214–220.

47.

Mishra

, Solanki

, Singh

, Goyal

. Prevalence and clinical correlates of comorbid attention deficit hyperactivity disorder in euthymic adults with bipolar disorder: a cross-sectional study. Indian J Psychiatry. 2023;65(11):1129–1136.

48.

Mishra

, Choudhury

, Chaudhary

, Saraswathy

, Shekhawat

, Devi

. Attention deficit hyperactivity disorder in obesity and hypertension: a study among young adults in Delhi NCR, India. Am J Hum Biol. 2025;37(3):e70022.

49.

Victor

, Gondwal

, Avinash

, Singhania

. Decoding the link between substance dependence and attention deficit hyperactivity disorder in adults: a cross-sectional study from North India. Ind Psychiatry J. 2023;32(2):397–401.

50.

Goyal

, Sudhir

, Mehta

, Prathyusha

, Kumar

, Benegal

. Adult ADHD presentations in an Indian tertiary care setting: gender perspectives. Asian J Psychiatry. 2025;106:104419.

51.

Singh

, Chatterjee

, Chauhan

. Prevalence of adult attention deficit hyperactivity disorder in patients of alcohol dependence syndrome: a cross-sectional study. Ind Psychiatry J. 2025;34(2):279–285.

52.

Singh

, Thakur

, Kumar

, Dogra

. Attention deficit hyperactivity disorder symptoms among students attending higher educational institution: a cross-sectional study. Open Neuroimaging J. 2024;17(1): 1–10.

53.

van Emmerik-van Oortmerssen

, van de Glind

, van den Brink

, . Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend. 2012;122(1-2):11–19.

54.

Molina

, Pelham

Jr.

Attention-deficit/hyperactivity disorder and risk of substance use disorder: developmental considerations, potential pathways, and opportunities for research. Annu Rev Clin Psychol. 2014;10:607–639.

55.

Larsson

, Dilshad

, Lichtenstein

, Barker

. Developmental trajectories of DSM-IV symptoms of attention-deficit/hyperactivity disorder: genetic effects, family risk and associated psychopathology. J Child Psychol Psychiatry. 2011;52(9):954–963.

56.

Quinn

, Madhoo

. A review of attention-deficit/hyperactivity disorder in women and girls: uncovering this hidden diagnosis. Prim Care Companion CNS Disord. 2014;16(3):PCC-13r01596.

57.

Robison

, Reimherr

, Marchant

, Faraone

, Adler

, West

. Gender differences in two clinical trials of adults with attention-deficit/hyperactivity disorder: a retrospective data analysis. J Clin Psychiatry. 2008;69(2):213–221.

58.

Trubanova

, Donlon

, Kreiser

, Ollendick

, White

. Underidentification of autism spectrum disorder in females: a case series illustrating the unique presentation of this disorder in young women. Scand J Child Adolesc Psychiatry Psychol. 2014;2(2):66–76.

59.

Young

, Adamo

, Ásgeirsdóttir

, . Females with ADHD: an expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit/hyperactivity disorder in girls and women. BMC Psychiatry. 2020;20(1):404.

60.

Comparelli

, Polidori

, Sarli

, Pistollato

, Pompili

. Differentiation and comorbidity of bipolar disorder and attention deficit and hyperactivity disorder in children, adolescents, and adults: a clinical and nosological perspective. Front Psychiatry. 2022;13:949375.

61.

Salvi

, Ribuoli

, Servasi

, Orsolini

, Volpe

. ADHD and bipolar disorder in adulthood: clinical and treatment implications. Medicina. 2021;57(5):466.

62.

Huntley

, Young

. Alcohol and substance use history among ADHD adults: the relationship with persistent and remitting symptoms, personality, employment, and history of service use. J Atten Disord. 2014;18(1):82–90.

63.

Wang

, Pedersen

, Joseph

, . Role of ADHD in the co-occurrence between heavy alcohol use and depression trajectories in adulthood. Alcohol Clin Exp Res. 2019;43(2):342–352.

64.

Jacob

, Romanos

, Dempfle

, . Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center. Eur Arch Psychiatry Clin Neurosci. 2007;257(6):309–317.

65.

Mao

, Findling

. Comorbidities in adult attention-deficit/hyperactivity disorder: a practical guide to diagnosis in primary care. Postgrad Med. 2014;126(5):42–51.

66.

Biederman

, Wilens

, Mick

, Faraone

, Spencer

. Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biol Psychiatry. 1998;44(4):269–273.

67.

Sullivan

, Rudnik-Levin

. Attention deficit/hyperactivity disorder and substance abuse: diagnostic and therapeutic considerations. Ann N Y Acad Sci. 2001;931(1):251–270.

68.

Wilens

, Upadhyaya

, Faraone

, Biederman

. Impact of substance use disorder on ADHD and its treatment. J Clin Psychiatry. 2007;68(8):e20.

69.

Biederman

, Faraone

, Mick

, . Attention-deficit hyperactivity disorder and juvenile mania: an overlooked comorbidity?. J Am Acad Child Adolesc Psychiatry. 1996;35(8):997–1008.

70.

Nierenberg

, Miyahara

, Spencer

, . Clinical and diagnostic implications of lifetime attention-deficit/ hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biol Psychiatry. 2005;57(11):1467–1473.

71.

Tamam

, Karakus

, Ozpoyraz

. Comorbidity of adult attention-deficit hyperactivity disorder and bipolar disorder: prevalence and clinical correlates. Eur Arch Psychiatry Clin Neurosci. 2008;258(7):385–393.

72.

Rostain

. Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management. Postgrad Med. 2008;120(3):27–38.

73.

Wakelin

, Willemse

, Munnik

. A review of recent treatments for adults living with attention-deficit/hyperactivity disorder. S Afr J Psychiatry. 2023;29(1):1–8.

74.

Nugent

, Smart

. Attention-deficit/hyperactivity disorder in postsecondary students. Neuropsychiatr Dis Treat. 2014; 10:1781–1791.

75.

Mohamad

, Rousseau

, Dowlut

, Gering

, Thomas

. Symptoms of ADHD and other common mental disorders influence academic success in South African undergraduates. J Atten Disord. 2025;29(5):363–386.

Concept,Prevalence and Clinical Profile of Adult ADHD with a Special Focus on India: A Systematic Review

Abstract

Purpose of the Review:

Collection and Analysis of Data:

Conclusions:

Keywords

Introduction

Methodology

Study Design

Search Strategy

Inclusion and Exclusion Criteria

Result and Discussion

Study Selection and Characteristics of Included Studies

Concept of ADHD

Prevalence of ADHD

Clinical Profile of ADHD

Conclusion

Footnotes

Declaration of Conflicting Interests

Funding

Statement of Informed Consent and Ethical Approval

References